- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06210763
IMT Outcomes in Sufferers of Severe Walking Disabilities and Intensive Care Unit Acquired Weakness
January 8, 2024 updated by: Ali Mohamed Ali ismail, Cairo University
Inspiratory Muscle Training Outcomes in Sufferers of Severe Walking Disabilities and Intensive Care Unit Acquired Weakness
Intensive care unit-acquired weakness (ICU-acquired weakness) may be caused by a variety of different causes.
Several studies have shown that ICU-acquired weakness occurs in up to 30% of critically ill patients.
It affects daily activities, walking, and functional performance
Study Overview
Status
Recruiting
Conditions
Detailed Description
Forty ICU-acquired weakness elderly patients will be randomly assigned to group A and group B, 20 elderly for each.
Both groups will receive chest physiotherapy (cough training, vibration, percussion, rib springing, and postural drainage), 30 minutes of resisted training on upper- and lower-limb muscles (15 min on upper limb and 15 min on lower limb), and 30 minutes of neuromuscular electrical stimulation of lower- and upper-limb muscles (triceps and wrist extensors, dorsiflexors, and quadriceps).
sessions will be executed 5 times weekly).
Group A only will receive 3-set IMT (two sessions daily via threshold IMT, the set contain 10 repetitions) 5 times weekly.
The study duration will be 1 month.
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ali MA Ismail, lecturer
- Phone Number: 01005154209
- Email: ali.mohamed@pt.cu.edu.eg
Study Contact Backup
- Name: hany elsisi, professor
- Email: elsisihany309@gmail.com
Study Locations
-
-
-
Giza, Egypt
- Recruiting
- Cairo Unoversity
-
Contact:
- Ali Ismail, lecturer
- Phone Number: 01005154209
- Email: allooka2012@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- sufferers with intensive care unit acquired weakness
- Older sufferers patients with severe walking disability detected by Modified Functional Ambulation Category test,
Exclusion Criteria:
- lower limb amputations
- orthopedic or spinal disc disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: group A
twenty ICU-acquired weakness elderly patients will receive chest physiotherapy (cough training, vibration, percussion, rib springing, and postural drainage), 30 minutes of resisted training on upper- and lower-limb muscles (15 min on upper limb and 15 min on lower limb), and 30 minutes of neuromuscular electrical stimulation of lower- and upper-limb muscles (triceps and wrist extensors, dorsiflexors, and quadriceps).
sessions will be executed 5 times weekly).
this Group will receive 3-set IMT (two sessions daily via threshold IMT, the set contain 10 repetitions) 5 times weekly.
The study duration will be 1 month.
|
twenty ICU-acquired weakness elderly patients will receive chest physiotherapy (cough training, vibration, percussion, rib springing, and postural drainage), 30 minutes of resisted training on upper- and lower-limb muscles (15 min on upper limb and 15 min on lower limb), and 30 minutes of neuromuscular electrical stimulation of lower- and upper-limb muscles (triceps and wrist extensors, dorsiflexors, and quadriceps).
sessions will be executed 5 times weekly).
this Group will receive 3-set IMT (two sessions daily via threshold IMT, the set contain 10 repetitions) 5 times weekly.
The study duration will be 1 month.
|
Active Comparator: group B
twenty ICU-acquired weakness elderly patients will receive chest physiotherapy (cough training, vibration, percussion, rib springing, and postural drainage), 30 minutes of resisted training on upper- and lower-limb muscles (15 min on upper limb and 15 min on lower limb), and 30 minutes of neuromuscular electrical stimulation of lower- and upper-limb muscles (triceps and wrist extensors, dorsiflexors, and quadriceps).
sessions will be executed 5 times weekly).
The study duration will be 1 month.
|
twenty ICU-acquired weakness elderly patients will receive chest physiotherapy (cough training, vibration, percussion, rib springing, and postural drainage), 30 minutes of resisted training on upper- and lower-limb muscles (15 min on upper limb and 15 min on lower limb), and 30 minutes of neuromuscular electrical stimulation of lower- and upper-limb muscles (triceps and wrist extensors, dorsiflexors, and quadriceps).
sessions will be executed 5 times weekly).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modified Functional Ambulation Category Test
Time Frame: it will be measured after 1 month
|
it is a category test used to assess walking disability
|
it will be measured after 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
functional vital capacity
Time Frame: It will be measured after 1 month
|
the percentage of predicted value of functional vital capacity will be assessed
|
It will be measured after 1 month
|
forced expiatory volume in the first second of expiration
Time Frame: It will be measured after 1 month
|
the percentage of predicted value of FEV1 will be assessed
|
It will be measured after 1 month
|
Partial Pressure of Oxygen
Time Frame: It will be measured after 1 month
|
it is an arterial blood gas test
|
It will be measured after 1 month
|
Partial Pressure of carbon dioxide
Time Frame: It will be measured after 1 month
|
it is an arterial blood gas test
|
It will be measured after 1 month
|
Oxygen saturation
Time Frame: It will be measured after 1 month
|
it is an arterial blood gas test
|
It will be measured after 1 month
|
inspiratory muscle strength
Time Frame: It will be measured after 1 month
|
it will be measure in cm H2O
|
It will be measured after 1 month
|
expiratory muscle strength
Time Frame: It will be measured after 1 month
|
it will be measure in cm H2O
|
It will be measured after 1 month
|
time up and go test
Time Frame: It will be measured after 1 month
|
it is time used to walk a three-meter distance
|
It will be measured after 1 month
|
30-second sit to stand
Time Frame: It will be measured after 1 month
|
number of (sit to stand) done in 30 seconds
|
It will be measured after 1 month
|
six-minute walk test,
Time Frame: It will be measured after 1 month
|
distance walked in 6 minute
|
It will be measured after 1 month
|
10-meter walking test
Time Frame: It will be measured after 1 month
|
it is time used to walk a 10-meter distance
|
It will be measured after 1 month
|
mental division of short form 36
Time Frame: It will be measured after 1 month
|
it assess mental component of short form 36 quality of life questionnare
|
It will be measured after 1 month
|
physical division of short form 36
Time Frame: It will be measured after 1 month
|
it assess physical component of short form 36 quality of life questionnare
|
It will be measured after 1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ali MA Ismail, lecturer, Cairo University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 2, 2023
Primary Completion (Estimated)
March 30, 2024
Study Completion (Estimated)
March 30, 2024
Study Registration Dates
First Submitted
January 8, 2024
First Submitted That Met QC Criteria
January 8, 2024
First Posted (Estimated)
January 18, 2024
Study Record Updates
Last Update Posted (Estimated)
January 18, 2024
Last Update Submitted That Met QC Criteria
January 8, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/004624
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intensive Care Unit Acquired Weakness
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
Universidade Federal do Rio de JaneiroHospital Universitario Pedro ErnestoNot yet recruitingIntensive Care Unit Acquired WeaknessBrazil
-
Federal University of Rio Grande do SulEnrolling by invitation
-
Medical Centre LeeuwardenCompletedCritical Illness | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit SyndromeNetherlands
-
Saglik Bilimleri UniversitesiMedical Park Hospital IstanbulCompletedIntensive Care Unit Acquired Weakness | Intensive Care (ICU) MyopathyTurkey
-
Hospital Felix BulnesCompletedMechanical Ventilation Complication | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Intensive Care Unit Delirium | Intensive Care NeuropathyChile
-
Associate Professor Sue Berney PhD, BPTCompletedIntensive Care Unit Acquired Weakness (ICUAW)United States, Australia
-
Okan UniversityNot yet recruitingIntensive Care Unit Acquired Weakness | Intensive Care, Intubated Patient, Early Mobilization, Mobilization, Respiratory PatternTurkey
-
Bartın UnıversityZonguldak Ataturk State HospitalCompletedSleep | Intensive Care Unit Acquired Weakness | Patient ComplianceTurkey
-
Charles University, Czech RepublicFaculty Hospital Kralovske VinohradyRecruitingIntensive Care Unit-acquired WeaknessCzechia
Clinical Trials on Threshold IMT and traditional physical therapy program
-
DR. JASSIM ALGHAITHUnknownCovid19 | Severe Systemic Illness Respiratory Muscle FatigueKuwait
-
Rabin Medical CenterUnknownLung TransplantationIsrael
-
Sherin Hassan Mohammed MehaniCompletedMechanical Ventilation ComplicationEgypt
-
Cairo UniversityNot yet recruitingDe Quervain DiseaseEgypt
-
Umm Al-Qura UniversityCompleted
-
Cairo UniversityCompleted
-
Taibah UniversityActive, not recruiting
-
Cairo UniversityCompleted
-
Pharos University in AlexandriaNot yet recruitingChronic Idiopathic Fatigue